Furthermore, we found that overexpression of Rbm17 significantly promoted HCC growth in immunocompetent C57BL/6 N mice, indicating that RBM17 may promote HCC progression by affecting immune cells (Fig. S1C). Here, RBM17 is linked to hepatocellular carcinoma.